APN 2018 Agenda
| SESSION | TOPIC | SPEAKER | COMPANY | TIME |
| Registration and Breakfast | 8:00AM-9:00AM | |||
| Conference Introductory Comments | Miles Miller | Harvard Medical School | 9:00AM-9:10AM | |
| Opening Plenary Lecture | Biomolecular Biosensors for Health Monitoring and Disease Detection | Greg Troiano | Seer, Inc. | 9:10AM-9:50AM |
Session I: Innovations in Nanotechnology
Session Chairs: Ursula Germann, OnKognos & InnovaTID and Mansoor Amiji, Northeastern University
| SESSION | TOPIC | SPEAKER | COMPANY | TIME |
| Session Introduction | 9:50AM-9:55AM | |||
| "Achievements, Disappointments, and Lessons Learned from Immunotoxicity Studies of Nanotechnology-Formulated Complex Drugs” | Marina Dobrovolskaia | Nanotechnology Characterization Lab | 9:55AM-10:25AM | |
| "Exosome Enrichment Enables Tissue Specific Liquid Biopsy Analysis" | Johan Skog | Exosome Diagnostics | 10:25AM-10:55AM | |
| Break | 10:55AM-11:15AM | |||
Session II: Break-Through Nanotechnologies
Session Chairs: Miles Miller, Harvard Medical School and Heidi Ferguson, Merck
| SESSION | TOPIC | SPEAKER | COMPANY | TIME |
| Session Introduction | 11:15AM-11:20AM | |||
| "Exosomes: A New Therapeutic Modality and the Technology for Their Large Scale Manufacturing" | Konstantin Konstantinov | Codiak BioSciences | 11:20AM-11:50AM | |
| "Robust In Vivo Editing of Hepatocyte Target DNA Mediated by Lipid Nanoparticle Delivery of CRISPR/Cas9 Components" | Kristy Wood | Intellia Therapeutics | 11:50AM-12:20PM | |
| Lunch | 12:20PM-1:20PM | |||
| "Messenger RNA as a Novel Therapeutic Approach" | Staci Sabnis | Moderna Therapeutics | 1:20PM-1:50PM | |
| Plenary Speaker Introduction | Mansoor Amiji | Northeastern University | 1:50PM-1:55PM | |
| Afternoon Plenary Lecture | Strategies to Overcome Biological Hurdles for Nanoparticle Circulation and Targeting | Samir Mitragotri |
Harvard | 1:55PM-2:35PM |
| Break | 2:35PM-2:50PM |
Session III: Transforming the Science into the Clinic
Session Chairs: Beata Sweryda-Krawiec, Tarveda Therapeutics and Maria Figueiredo, Pfizer
| SESSION | TOPIC | SPEAKER | COMPANY | TIME |
| Session Introduction | 2:50PM-2:55PM | |||
| "ACCURINS Polymeric Nanoparticles: Considerations for Scale-up and Tech Transfer" | Ken Bernstein | Pfizer | 2:55PM-3:25PM | |
| "Clinical Translation of Non-targeted and Antibody-targeted Nanotherapeutics into the Clinic: Opportunities and Challenges" | Daryl Drummond | Merrimack Pharmaceuticals | 3:25PM-3:55PM | |
| Panel Discussion - Translation to the Clinic | 3:55PM-4:15PM | |||
| Plenary Speaker Introduction | Sara Movassaghian | Forma Therapeutics | 4:15PM-4:20PM | |
| Plenary Lecture | "Next Generation of Drug Delivery Systems: Stimuli-Sensitive Combination Nanopreparations for Cancer" | Vladimir Torchilin |
Northeastern University | 4:20PM-5:00PM |
| Closing Remarks | Maria Figueiredo | Pfizer | 5:00PM-5:05PM | |
| Poster Session and Evening Reception | 5:05PM-6:15PM |